Subsite-specific benefit of induction chemoimmunotherapy in HPV-negative oropharyngeal squamous cell carcinoma.

Front Oncol · 2026 · PMC13293886 · PMID 42370167

Europe PMC DOI

hedged sentence

0.1650

closest p · 3.3× alpha

0.1650

boldest claim

The sentences

a nonsignificant trendP = .165not close (p > 0.1)

In univariable analysis, induction chemotherapy plus ICI showed a nonsignificant trend toward improved PFS compared with chemotherapy alone (HR, 0.43; 95% CI, 0.13 to 1.42; P = .165).

also in 5,406 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.